1. Home
  2. BIO vs KNSL Comparison

BIO vs KNSL Comparison

Compare BIO & KNSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • KNSL
  • Stock Information
  • Founded
  • BIO 1952
  • KNSL 2009
  • Country
  • BIO United States
  • KNSL United States
  • Employees
  • BIO N/A
  • KNSL N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • KNSL Property-Casualty Insurers
  • Sector
  • BIO Industrials
  • KNSL Finance
  • Exchange
  • BIO Nasdaq
  • KNSL Nasdaq
  • Market Cap
  • BIO 7.7B
  • KNSL 10.5B
  • IPO Year
  • BIO N/A
  • KNSL 2016
  • Fundamental
  • Price
  • BIO $282.14
  • KNSL $423.33
  • Analyst Decision
  • BIO Strong Buy
  • KNSL Buy
  • Analyst Count
  • BIO 4
  • KNSL 10
  • Target Price
  • BIO $333.50
  • KNSL $506.44
  • AVG Volume (30 Days)
  • BIO 225.4K
  • KNSL 183.5K
  • Earning Date
  • BIO 10-29-2025
  • KNSL 10-23-2025
  • Dividend Yield
  • BIO N/A
  • KNSL 0.16%
  • EPS Growth
  • BIO N/A
  • KNSL 20.44
  • EPS
  • BIO 11.49
  • KNSL 19.16
  • Revenue
  • BIO $2,554,200,000.00
  • KNSL $1,723,392,000.00
  • Revenue This Year
  • BIO $2.12
  • KNSL $15.65
  • Revenue Next Year
  • BIO $2.90
  • KNSL $9.31
  • P/E Ratio
  • BIO $24.23
  • KNSL $22.11
  • Revenue Growth
  • BIO N/A
  • KNSL 21.12
  • 52 Week Low
  • BIO $211.43
  • KNSL $405.00
  • 52 Week High
  • BIO $387.99
  • KNSL $531.79
  • Technical
  • Relative Strength Index (RSI)
  • BIO 49.68
  • KNSL 35.00
  • Support Level
  • BIO $277.40
  • KNSL $422.94
  • Resistance Level
  • BIO $298.00
  • KNSL $437.93
  • Average True Range (ATR)
  • BIO 7.49
  • KNSL 10.08
  • MACD
  • BIO -2.66
  • KNSL -2.92
  • Stochastic Oscillator
  • BIO 23.10
  • KNSL 4.52

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About KNSL Kinsale Capital Group Inc.

Kinsale Capital Group Inc is an insurance holding company. The company is engaged in offering property, casualty, and specialty insurance products. It offers specialty insurance products for allied health, healthcare, life sciences, professional, and a public entity. The company operates in only one reportable segment which is the Excess and Surplus Lines Insurance segment, which includes commercial excess and surplus lines liability and property insurance products through its underwriting divisions. The company generates revenues in the form of premiums and investment income.

Share on Social Networks: